Grown Rogue International (GRUSF) Finished Goods (2017 - 2026)
Grown Rogue International's (GRUSF) quarterly Finished Goods came in at $4.8 million in Q1 2026, up 265.09% year-on-year from $1.3 million in Q1 2025, and up 1.59% quarter-over-quarter from $4.8 million in Q4 2025.
Grown Rogue International (GRUSF) Finished Goods (2017 - 2026) Analysis & Trends
Grown Rogue International's Finished Goods history runs 10 years deep, the most recent figure standing at $4.8 million for Q1 2026.
- On a quarterly basis, Finished Goods rose 265.09% year-over-year to $4.8 million in Q1 2026; TTM through Mar 2026 was $4.8 million, a 265.09% increase from a year earlier, with the FY2025 full-year figure at $4.8 million, up 137.04% from the prior year.
- Finished Goods rose to $4.8 million in Q1 2026 per GRUSF's latest filing, from $4.8 million in the prior quarter.
- Across five years, Finished Goods topped out at $4.8 million in Q1 2026 and bottomed at -$9894.3 billion in Q3 2024.
- The 5-year median for Finished Goods is -$2.8 million (2024), against an average of -$1202.3 billion.
- Across the five-year window, Finished Goods sank 536.84% in 2022 and jumped 377.09% in 2024, its largest moves.
- Year by year, Finished Goods stood at -$9.2 million in 2022, then soared by 84.78% to -$1.4 million in 2023, then soared by 377.09% to $3.9 million in 2024, then grew by 22.09% to $4.8 million in 2025, then gained by 1.59% to $4.8 million in 2026.
- Per Business Quant, the three latest GRUSF Finished Goods figures stand at $4.8 million (Q1 2026), $4.8 million (Q4 2025), and -$9342.0 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Grown Rogue International | 99.97 Mn | 92.67 Mn | 3.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.83 Mn |
| Dec 31, 2025 | 4.75 Mn |
| Sep 30, 2025 | -9,342.00 Bn |
| Jun 30, 2025 | -6.15 Mn |
| Mar 31, 2025 | -2.92 Mn |
| Dec 31, 2024 | 3.89 Mn |
| Sep 30, 2024 | -9,894.32 Bn |
| Jun 30, 2024 | -6.34 Mn |
| Mar 31, 2024 | -2.77 Mn |
| Dec 31, 2023 | -1.40 Mn |
| Oct 31, 2023 | -2.22 Mn |
| Jul 31, 2023 | -6.11 Mn |
| Apr 30, 2023 | -3.06 Mn |
| Jan 31, 2023 | -2.04 Mn |
| Oct 31, 2022 | -9.23 Mn |
| Jan 31, 2022 | -1.70 Mn |
| Oct 31, 2021 | -4.00 Mn |
| Jul 31, 2021 | -2.58 Mn |
| Apr 30, 2021 | -1.35 Mn |
| Jan 31, 2021 | 388,933.00 |